PD-145 Long-term survival of NSCLC patients with EGFR mutationstreated with EGFR TKIs gefitinib or erlotinibP JANNE,L SEQUIST,N LINDEMAN,D BELL, M HUBERMAN, M MEYERSON,D HABER,T LYNCH,B JOHNSONLung Cancer（2005）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
